VANCOUVER, British Columbia, December 07, 2021 (GLOBE NEWSWIRE) – ELSE NUTRITION HOLDINGS INC. (TSX-V: BABY) (OTCQB: BABYF) (FSE: 0YL) (“Different” or the “society”), the plant-based baby, toddler and toddler nutrition company, today announced that it will attend Lytham Partners Winter 2021 Winter 2021 Investors Conference, which will take place December 13-16, 2021. During the event, the company will webcast Fireside Chat to discuss its vision for 2022 and hold virtual 1×1 investor meetings.
The webcast fireside chat will air on Monday, December 13, 2021 at 11:00 a.m. ET on the company’s website at https://elsenutrition.com/pages/investor-relations or https://wsw.com/ webcast / are available. lytham3 / babyf / 2166600. The webcast will also be available for playback after the event.
To schedule a 1×1 meeting with management, please contact Lytham Partners at 1×1@lythampartners.com or register at www.lythampartners.com/winter2021invreg.
About Else Nutrition Holdings Inc.
Else Nutrition GH Ltd. is an Israel-based food and nutrition company focused on developing innovative, clean and plant-based foods and nutritional products for infants, toddlers, children and adults. Its revolutionary, herbal formula without soy is an alternative to pure milk-based ingredients. Else Nutrition (formerly INDI) was awarded the “2017 Best Health and Diet Solutions” award at the Global Food Innovation Summit in Milan. The plant-based complete food for toddlers from Else was recently classified as the number 1 top seller in the baby and toddler food category on Amazon. The holding company Else Nutrition Holdings Inc. is a publicly traded company, traded as the TSX Venture Exchange under the symbol BABY and on the US OTC Markets QX Board under the symbol BABYF and on the Frankfurt Stock Exchange under the symbol 0YL. written down . Else executives include executives from leading baby food companies. Many of Else’s advisory board members have held previous leadership positions at companies such as Mead Johnson, Abbott Nutrition, Plum Organics, and leading infant nutrition companies, and some of them are currently in various roles at leading medical centers and academic institutions such as Boston Children’s Hospital, Pediatrics at Harvard Medical School, USA, Tel Aviv University, Schneider Children’s Medical Center of Israel, Rambam Medical Center and Technion, Israel and University Hospital Brussels, Belgium.
You can find more information at: elsenutrition.com or @elsenutrition on Facebook and Instagram.
Media contact
Erin Jundef
Brilliant PR
erinj@brilliantpr.com
For more information contact:
Ms. Hamutal Yitzhak, CEO, Co-Founder and Director
ELSE Nutrition Holdings Inc.
E: hamutaly@elsenutrition.com
Phone: +972 (0) 3-6445095
Mr. Sokhie Puar, Director of Else Nutrition
E: sokhiep@elsenutrition.com
P: 604-603-7787
US Investor Relations Contact:
Lytham Partners, LLC
Mr. Ben Shamsian
New York | Phoenix
E: shamsian@lythampartners.com
P: 646-829-9701
TSX Venture Exchange
Neither the TSX Venture Exchange nor its regulator (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this press release.
Beware of forward-looking statements
This press release contains statements that may constitute “forward-looking statements” within the meaning of applicable securities laws. Forward-looking statements are usually identified by words such as “will”, “expect” or similar expressions. Forward-looking statements in this press release include statements regarding the anticipated dates for filing the company’s financial disclosure documents. Such forward-looking statements reflect current estimates, beliefs and assumptions that are based on management’s perception of current conditions and expected future developments, as well as other factors that management considers appropriate under the given circumstances. There can be no assurance that the foregoing will prove to be correct. Forward-looking statements in this press release assume, among other things, that the listing on the Frankfurt Stock Exchange will create additional liquidity and attract additional investors to the European market. Actual results could differ from the estimates, beliefs and assumptions expressed or implied in the forward-looking statements. Readers are cautioned not to place undue reliance on forward-looking statements, which speak only about management’s expectations as of the date of this press release. The company disclaims any obligation to update or revise any forward-looking statements as a result of new information, future events or for any other reason, except as required by law.
